January 3rd According to a Reuters report, Mexican health authorities confirmed on the evening of the 1st local time that a 32-year-old female doctor in the country began to convulse and have difficulty breathing after being vaccinated against the Pfizer-BioNTech coronavirus vaccine.
At present, Mexico is currently conducting research on the case of severe adverse reactions to the vaccine. Research.
It is understood that the female doctor suffered from convulsions, rashes, muscle weakness, dyspnea and other symptoms within 30 minutes of vaccination, and was immediately sent to the hospital intensive care unit for treatment.
The initial diagnosis of the patient was encephalomyelitis, the Mexican health department said in a statement. At the same time, the health department added that doctors have a history of allergic reactions, but there is no evidence in clinical trials that vaccination can cause encephalomyelitis.
So far, Pfizer and its partner BioNTech have not responded immediately.
Previously, Mexico launched the coronavirus vaccination on December 24, 2020, with more than 2,900 medical staff participating in the front-line fight against the epidemic.
According to foreign media on January 1, the World Health Organization officially authorized Pfizer-BioNTech to use the coronavirus vaccine urgently, which aims to speed up the acquisition of the coronavirus vaccine in developing countries.
Reuters reported that the WHO said it would work with regional partners to provide national health authorities with information on vaccination and its expected benefits.